Abeona Therapeutics Inc. – NASDAQ:ABEO

Abeona Therapeutics stock price today

$6.92
+1.29
+22.91%
Financial Health
0
1
2
3
4
5
6
7
8
9

Abeona Therapeutics stock price monthly change

+2.18%
month

Abeona Therapeutics stock price quarterly change

+2.18%
quarter

Abeona Therapeutics stock price yearly change

+9.96%
year

Abeona Therapeutics key metrics

Market Cap
245.17M
Enterprise value
16.28M
P/E
-0.53
EV/Sales
5.90
EV/EBITDA
-0.25
Price/Sales
8.28
Price/Book
0.85
PEG ratio
N/A
EPS
-3.21
Revenue
N/A
EBITDA
-47.45M
Income
-76.65M
Revenue Q/Q
N/A
Revenue Y/Y
492.13%
Profit margin
-2629.13%
Oper. margin
-2880.94%
Gross margin
23.55%
EBIT margin
-2880.94%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Abeona Therapeutics stock price history

Abeona Therapeutics stock forecast

Abeona Therapeutics financial statements

Abeona Therapeutics Inc. (NASDAQ:ABEO): Profit margin
Jun 2023 3.5M -16.65M -475.83%
Sep 2023 0 -11.83M
Dec 2023 2.82M -16.59M -587.5%
Mar 2024 0 -31.57M
Abeona Therapeutics Inc. (NASDAQ:ABEO): Analyst Estimates
Dec 2023 2.82M -16.59M -587.5%
Mar 2024 0 -31.57M
Oct 2025 3.75M -9.01M -240.38%
Dec 2025 12.75M -3.96M -31.06%
  • Analysts Price target

  • Financials & Ratios estimates

Abeona Therapeutics Inc. (NASDAQ:ABEO): Debt to assets
Jun 2023 53550000 44.20M 82.55%
Sep 2023 66087000 44.04M 66.65%
Dec 2023 64001999 49.17M 76.84%
Mar 2024 74828000 83.70M 111.87%
Abeona Therapeutics Inc. (NASDAQ:ABEO): Cash Flow
Jun 2023 -10.28M 5.21M 6.61M
Sep 2023 -5.74M -18.74M 22.97M
Dec 2023 -9.23M 11.52M 7.46M
Mar 2024 -14.53M -7.81M 25.44M

Abeona Therapeutics alternative data

Abeona Therapeutics Inc. (NASDAQ:ABEO): Employee count
Aug 2023 57
Sep 2023 57
Oct 2023 57
Nov 2023 57
Dec 2023 57
Jan 2024 57
Feb 2024 57
Mar 2024 84
Apr 2024 84
May 2024 84
Jun 2024 84
Jul 2024 84

Abeona Therapeutics other data

100.00% 0.00%
of ABEO is owned by hedge funds
1.42M -6.75M
shares is hold by hedge funds

Abeona Therapeutics Inc. (NASDAQ:ABEO): Insider trades (number of shares)
Period Buy Sel
Sep 2023 26000 34057
Jan 2024 0 7084
Feb 2024 20000 0
Apr 2024 31758 0
May 2024 2959475 0
Jun 2024 0 51711
Transaction Date Insider Security Shares Price per share Total value Source
Sale
ALVINO MARK director
Common Stock 25,890 $4.51 $116,764
Sale
SILVERSTEIN CHRISTINE BERNI director
Common Stock 25,821 $4.51 $116,453
Purchase
ALLAND LEILA director Common Stock 11,000 $4.71 $51,799
Purchase
ADAGE CAPITAL MANAGEMENT, L.P. 10 percent owner
Pre-funded Warrant (right to buy) 2,948,475 N/A N/A
Purchase
CHARLES FAITH L. director
Common Stock 7,550 $3.28 $24,764
Purchase
SESHADRI VISHWAS director, officer: Chief Execut..
Common Stock 10,000 $3.2 $32,000
Purchase
O'MALLEY BRENDAN M. officer: SVP, General Counsel
Common stock 8,600 $3.24 $27,864
Purchase
VAZZANO JOSEPH WALTER officer: Chief Fi.. Common stock 5,608 $3.14 $17,609
Purchase
SESHADRI VISHWAS director, officer: Chief Execut..
Common Stock 20,000 $4.39 $87,800
Sale
ALVINO MARK director
Common Stock 7,084 $5.11 $36,199
Thursday, 14 November 2024
globenewswire.com
Tuesday, 12 November 2024
globenewswire.com
Monday, 4 November 2024
globenewswire.com
Friday, 1 November 2024
globenewswire.com
Tuesday, 29 October 2024
globenewswire.com
Thursday, 3 October 2024
seekingalpha.com
Tuesday, 1 October 2024
globenewswire.com
Tuesday, 3 September 2024
globenewswire.com
Monday, 2 September 2024
globenewswire.com
Wednesday, 14 August 2024
globenewswire.com
Tuesday, 13 August 2024
globenewswire.com
Monday, 12 August 2024
globenewswire.com
Thursday, 1 August 2024
globenewswire.com
Friday, 12 July 2024
seekingalpha.com
Thursday, 11 July 2024
globenewswire.com
Monday, 8 July 2024
globenewswire.com
Sunday, 9 June 2024
accesswire.com
Friday, 7 June 2024
prnewswire.com
Wednesday, 5 June 2024
globenewswire.com
Monday, 3 June 2024
globenewswire.com
Saturday, 1 June 2024
accesswire.com
Thursday, 30 May 2024
prnewswire.com
Tuesday, 28 May 2024
globenewswire.com
Thursday, 23 May 2024
prnewswire.com
Thursday, 16 May 2024
prnewswire.com
Wednesday, 15 May 2024
globenewswire.com
Tuesday, 7 May 2024
globenewswire.com
Monday, 6 May 2024
prnewswire.com
Friday, 3 May 2024
globenewswire.com
Thursday, 2 May 2024
Seeking Alpha
  • What's the price of Abeona Therapeutics stock today?

    One share of Abeona Therapeutics stock can currently be purchased for approximately $6.92.

  • When is Abeona Therapeutics's next earnings date?

    Unfortunately, Abeona Therapeutics's (ABEO) next earnings date is currently unknown.

  • Does Abeona Therapeutics pay dividends?

    No, Abeona Therapeutics does not pay dividends.

  • How much money does Abeona Therapeutics make?

    Abeona Therapeutics has a market capitalization of 245.17M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 147.52% to 3.5M US dollars.

  • What is Abeona Therapeutics's stock symbol?

    Abeona Therapeutics Inc. is traded on the NASDAQ under the ticker symbol "ABEO".

  • What is Abeona Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Abeona Therapeutics?

    Shares of Abeona Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Abeona Therapeutics's key executives?

    Abeona Therapeutics's management team includes the following people:

    • Mr. Edward G. Carr Senior Vice President, Chief Financial Officer & Chief Accounting Officer(age: 56, pay: $437,400)
  • How many employees does Abeona Therapeutics have?

    As Jul 2024, Abeona Therapeutics employs 84 workers.

  • When Abeona Therapeutics went public?

    Abeona Therapeutics Inc. is publicly traded company for more then 44 years since IPO on 19 Sep 1980.

  • What is Abeona Therapeutics's official website?

    The official website for Abeona Therapeutics is abeonatherapeutics.com.

  • Where are Abeona Therapeutics's headquarters?

    Abeona Therapeutics is headquartered at 1330 Avenue of the Americas, New York, NY.

  • How can i contact Abeona Therapeutics?

    Abeona Therapeutics's mailing address is 1330 Avenue of the Americas, New York, NY and company can be reached via phone at +64 6 813 4701.

Abeona Therapeutics company profile:

Abeona Therapeutics Inc.

abeonatherapeutics.com
Exchange:

NASDAQ

Full time employees:

84

Industry:

Biotechnology

Sector:

Healthcare

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.

1330 Avenue of the Americas
New York, NY 10019

CIK: 0000318306
ISIN: US00289Y2063
CUSIP: 00289Y107